arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Wellgistics Health, Inc.

WGRX

$3.50 0.00 (0.00%) at close

4 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Moderately Bearish

auto_awesome

Analytical Summary

Wellgistics Health, Inc. faces fundamental challenges. On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $248.5M

Dividend Yield —

Revenue Growth 28.7%

Op. Margin -401.7% ↘

ROIC -670.9% ↘

FCF / Share $-0.15 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity -1.89

info Valuation on last close. End-of-day price, Jul 21, 2026.

4-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$23.34M

↑ +28.7% —

Net Income Profit after all expenses

$-101.27M

↓ -1377.1% —

Operating Margin Operating profit as % of sales

-401.7%

↓ -1085.1% 0th

FCF / Share Free cash flow per share

$-0.15

↓ -489.9% —

Long-Term Debt Long-term obligations

$23.49M

— +0.4% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Revenue Growth YoY (%)	28.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+259%)	—	—	—
EPS Growth YoY (%)	-853.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-150.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-1377.1% Weak Weak Year-over-year change in net income	-136.8% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-489.9% Weak Weak Year-over-year change in free cash flow	-232.1% Weak Weak Year-over-year change in free cash flow	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Operating Margin (%) (%)	-401.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2778%)	-33.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-326%)	—	—
Profit Margin (%) (%)	-433.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3716%)	-37.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-415%)	—	—
FCF Margin (%) (%)	-46.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-6.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	0.11x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.18x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.12x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Return on Invested Capital (%)	-670.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	78.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-307.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-851.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	-101.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-779%)	99.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+566%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Debt to Equity (x)	-1.89x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-414%)	3.47x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+479%)	—	—
Interest Coverage (x)	-30.14x Weak Weak Operating income divided by interest expense Optimal: > 5x	-18.46x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$23.44M	$22.35M	$-1.36K	—
Debt / EBITDA (x)	-0.25x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-3.85x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Revenue per Share (USD)	$0.33	$0.38	—	—
Basic EPS, GAAP (USD)	$-1.43	$-0.15	$-0.06	—
Free Cash Flow per Share (USD)	$-0.15	$-0.03	$-0.01	—
Book Value per Share (USD)	$-0.12	$0.13	$-0.06	—
Tangible Book Value per Share (USD)	$-0.29	$-0.22	$-0.06	—
Basic Weighted Avg Shares (shares)	70.99M	47.25M	44.72M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$-26.96M	$-22.88M	$-2.55M	—
LT Debt (USD)	$23.49M	$23.38M	—	—
Total Equity (USD)	$-12.45M	$6.73M	$-2.90M	$-5.25K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$23.34M	$18.13M	—	—
Depreciation Expense (USD)	$158.80K	$67.62K	—	—
Net Income, GAAP (USD)	$-101.27M	$-6.86M	$-2.90M	—
Operating Cash Flow (USD)	$-10.86M	$-1.22M	$-349.14K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 11 quarters

Wellgistics Health, Inc.

Analytical Summary

4-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare WGRX with peers